You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 11,179,403


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,179,403 protect, and when does it expire?

Patent 11,179,403 protects JATENZO and is included in one NDA.

This patent has twenty-nine patent family members in fourteen countries.

Summary for Patent: 11,179,403
Title:Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
Abstract: A pharmaceutical formulation of testosterone undecanoate is provided. Methods of treating a testosterone deficiency or its symptoms with the inventive formulations are also provided.
Inventor(s): Dudley; Robert E. (Murfreesboro, TN), Constantinides; Panayiotis P. (Gurnee, IL)
Assignee: Clarus Therapeutics, Inc. (Northbrook, IL)
Application Number:16/656,157
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Delivery; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 11,179,403

Introduction

Understanding the scope and claims of a patent is crucial for navigating the complex landscape of intellectual property. This analysis will delve into the specifics of United States Patent 11,179,403, exploring its claims, scope, and the broader patent landscape.

Overview of Patent 11,179,403

United States Patent 11,179,403, while not explicitly detailed in the provided sources, can be analyzed using general principles of patent analysis.

Patent Claims

Patent claims are the most critical part of any patent application, as they define the scope of the invention and what is protected by the patent. Here are some key points to consider:

  • Claim Structure: Patent claims typically include independent and dependent claims. Independent claims stand alone and define the broadest scope of the invention, while dependent claims narrow down the scope by adding additional limitations[3].
  • Claim Clarity: Clear and concise claim language is essential for ensuring that the patent meets statutory requirements. The USPTO has emphasized the importance of clear, concise, and exact terms in patent applications to avoid broadly worded claims that can complicate the examination process[1].

Scope of the Patent

The scope of a patent is determined by the claims and is a critical factor in patent quality and validity.

  • Metrics for Measuring Scope: Research has suggested using metrics such as independent claim length and independent claim count to measure patent scope. Narrower claims, as indicated by shorter lengths and fewer counts, are often associated with a higher probability of grant and a shorter examination process[5].
  • Claim Charts and Scope Concepts: Tools like claim charts and scope concepts can help in analyzing the patent landscape. These tools categorize patents by claims and overarching scope concepts, making it easier to determine whether a particular scope concept is applicable to a target product or method[3].

Patent Quality and Clarity

The quality and clarity of patent claims are pivotal in ensuring that the patent is valid and enforceable.

USPTO Initiatives

The USPTO has undertaken several initiatives to improve patent quality:

  • Enhanced Patent Quality Initiative: This initiative aims to improve the clarity and consistency of patent examinations. It includes measures such as analyzing performance incentives, reassessing examination time, and considering the use of claim clarity tools[1].
  • Application Readiness Review Form (ARRF): USPTO has developed the ARRF to score applications based on their readiness, helping to identify whether an applicant has provided sufficient information for an effective application[1].

Impact of Broad Claims

Broadly worded patent claims can lead to difficulties in the examination process and may result in patents that do not meet statutory requirements. Nearly 90% of patent examiners encounter broadly worded claims, which can hinder thorough examinations[1].

Legal and Regulatory Framework

Understanding the legal and regulatory framework is essential for interpreting the scope and claims of a patent.

Statutory Requirements

Patent applications must meet statutory requirements such as novelty, clarity, and written description. The USPTO calculates compliance rates for these requirements, which are available on its website[1].

Court Decisions

Court decisions can provide insights into how patent claims are interpreted and validated. For example, the case of Allergan USA, Inc. v. MSN Laboratories Private Ltd. highlights the importance of written description and the validity of claims under 35 U.S.C. § 112[4].

Patent Analytics and Landscape

Patent analytics plays a crucial role in understanding the patent landscape and identifying gaps or opportunities.

Claim Coverage Matrix

A Claim Coverage Matrix helps in categorizing patents by claims and scope concepts, enabling a comprehensive analysis of the patent landscape. This tool is particularly useful for large portfolios, as it becomes more efficient with more data[3].

Interactive Claim Charts

Interactive claim charts generated by software like ClaimScape® facilitate the review of patent coverage with technical experts. These charts help in determining whether a particular scope concept is applicable to a target product or method and highlight areas where claim coverage is lacking[3].

Practical Applications

Understanding the scope and claims of a patent has several practical applications:

Innovation and Licensing

Clear and well-defined claims can reduce licensing and litigation costs, thereby promoting innovation. Overly broad or unclear claims can lead to increased costs and diminished incentives for innovation[5].

Competitive Strategy

Analyzing the patent landscape helps companies in identifying future design opportunities and gaps in their current coverage. This information is crucial for developing a competitive strategy and ensuring that intellectual property is adequately protected[3].

Key Takeaways

  • Clear Claims: Clear and concise claim language is essential for ensuring patent quality and validity.
  • Scope Metrics: Metrics such as independent claim length and count can help in measuring patent scope.
  • USPTO Initiatives: The USPTO's Enhanced Patent Quality Initiative and other measures aim to improve patent clarity and consistency.
  • Legal Framework: Understanding statutory requirements and court decisions is crucial for interpreting patent claims.
  • Patent Analytics: Tools like Claim Coverage Matrix and interactive claim charts are vital for analyzing the patent landscape.

FAQs

Q: What are the key components of a patent claim? A: The key components include independent and dependent claims, with independent claims defining the broadest scope of the invention and dependent claims narrowing it down.

Q: Why is claim clarity important? A: Claim clarity is essential for ensuring that the patent meets statutory requirements and can be thoroughly examined by the USPTO.

Q: How does the USPTO measure patent quality? A: The USPTO measures patent quality through correctness measures and quantifiable compliance targets, which include statutory compliance rates for various sections of the U.S.C.

Q: What is the role of patent analytics in understanding the patent landscape? A: Patent analytics helps in categorizing patents by claims and scope concepts, identifying gaps or opportunities, and determining the applicability of scope concepts to target products or methods.

Q: How do court decisions impact the interpretation of patent claims? A: Court decisions provide interpretations of statutory requirements and can validate or invalidate claims based on factors such as written description and obviousness-type double patenting.

Sources

  1. GAO Report: Intellectual Property: Patent Office Should Define Quality, Reassess Incentives, and Consider Additional Tools to Improve Patent Quality.
  2. Drug Patent Watch: Summary for Patent: 11,179,403.
  3. Schwegman: Patent Analytics.
  4. CAFC Opinion: Allergan USA, Inc. v. MSN Laboratories Private Ltd.
  5. SSRN Paper: Patent Claims and Patent Scope.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 11,179,403

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Tolmar JATENZO testosterone undecanoate CAPSULE;ORAL 206089-001 Mar 27, 2019 RX Yes No 11,179,403 ⤷  Subscribe METHOD OF TREATING TESTOSTERONE DEFICIENCY ⤷  Subscribe
Tolmar JATENZO testosterone undecanoate CAPSULE;ORAL 206089-002 Mar 27, 2019 RX Yes No 11,179,403 ⤷  Subscribe METHOD OF TREATING TESTOSTERONE DEFICIENCY ⤷  Subscribe
Tolmar JATENZO testosterone undecanoate CAPSULE;ORAL 206089-003 Mar 27, 2019 RX Yes Yes 11,179,403 ⤷  Subscribe METHOD OF TREATING TESTOSTERONE DEFICIENCY ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,179,403

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2006236564 ⤷  Subscribe
Australia 2011201422 ⤷  Subscribe
Brazil PI0607549 ⤷  Subscribe
Canada 2604943 ⤷  Subscribe
China 101217963 ⤷  Subscribe
Denmark 2985026 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.